Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc62792656aa2e858252e97e5ffaca79 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 |
filingDate |
2016-08-01^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-05-16^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71cc834ebec69a538504722992876363 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8df2ce151a19165553164c135c204bc1 |
publicationDate |
2017-05-16^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9650365-B2 |
titleOfInvention |
Itraconazole analogues and methods of use thereof |
abstract |
Disclosed herein are analogs of itraconazole that are both angiogenesis and hedgehog signaling pathway inhibitors. The compounds are expected to be useful in the treatment of cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9968600-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363252-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328072-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11390613-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962381-B2 |
priorityDate |
2014-02-01^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |